| abstract |
A 3,4-dihydroisoquinoline derivative compound of formula (I) or a non-toxicnsalt thereof and a pharmaceutical agent comprising it as active ingredientn(wherein all symbols have the same meaning as described in the specification).nThe compound of formula (I) has agonizing activity on CB2 receptor andntherefore it is useful for the prophilaxis and/or treatment of various diseasesnsuch as asthma, nasal allergy, atopic dermatitis, autoimmune diseases,nrheumatoid arthritis, immune dysfunction, postoperative pain, carcinomatousnpain, etc. |